A PHASE-I CLINICAL-TRIAL FOR PATIENTS WITH METASTATIC MELANOMA USING AUTOLOGOUS IL2 SECRETING MELANOMA AS A VACCINE

Citation
K. Palmer et al., A PHASE-I CLINICAL-TRIAL FOR PATIENTS WITH METASTATIC MELANOMA USING AUTOLOGOUS IL2 SECRETING MELANOMA AS A VACCINE, Cancer gene therapy, 4(6), 1997, pp. 121-121
Citations number
1
Journal title
ISSN journal
09291903
Volume
4
Issue
6
Year of publication
1997
Supplement
S
Pages
121 - 121
Database
ISI
SICI code
0929-1903(1997)4:6<121:APCFPW>2.0.ZU;2-C